Reckitt Benckiser

Public consensus   -   Last updated 09/10/20

Contributors

  • 16 FY20 based on
  • 16 Q3 FY20 based on
  • 11 Q3 YTD FY20 based on
  • 16 FY21 based on
  • 16 FY22 based on
Reporting currency: GBP
Reporting unit: Millions
FY20
CONSENSUS
09/10/20
Q3 FY20
CONSENSUS
09/10/20
Q3 YTD FY20
CONSENSUS
09/10/20
FY21
CONSENSUS
09/10/20
FY22
CONSENSUS
09/10/20
Reckitt Benckiser Group Plc
Net Revenue Growth: Like for Like %
IFCN
(2.3)
(1.2)
(3.7)
3.6
3.0
OTC
2.1
(6.1)
5.2
2.0
4.0
Other
20.8
20.9
20.7
(1.9)
4.8
Total Health
7.3
6.0
8.0
0.6
4.0
Hygiene
14.6
15.2
15.8
(1.4)
4.2
Group growth: like-for-like %
10.2
9.5
11.1
(0.1)
4.1
Net M&A impact %
0.0
(2.8)
(0.3)
-
-
FX impact %
(2.1)
(4.3)
(2.5)
(0.6)
(0.2)
Group growth: Net Revenue growth (Actual rates) - continuing operations %
8.0
5.0
8.1
(0.7)
4.1
Net Revenue - Total Reported £
IFCN
2,854
695
2,119
2,923
3,006
OTC
1,957
443
1,411
1,982
2,059
Other
3,398
845
2,596
3,290
3,447
Total Health
8,209
1,982
6,126
8,196
8,512
Hygiene
5,652
1,460
4,202
5,561
5,790
Total Net Revenue
13,863
3,440
10,324
13,761
14,297
Operating Profit - Adjusted
Health
1,906
n/a
-
1,850
2,018
Hygiene
1,399
n/a
-
1,342
1,442
Total Operating Profit - Adjusted
3,305
n/a
-
3,192
3,460
Operating Margin % - Adjusted
Health
23.2
n/a
n/a
22.6
23.7
Hygiene
24.8
n/a
n/a
24.2
25.0
Total Operating Margin % - Adjusted
23.9
n/a
n/a
23.2
24.2
Net Finance Expense - Adjusted
(301)
n/a
n/a
(280)
(249)
Taxation (expense)/benefit - Adjusted
(685)
n/a
n/a
(666)
(735)
Non-controlling Interest
(15)
n/a
n/a
(15)
(16)
Continuing Operations
Net income - adjusted
2,297
n/a
n/a
2,231
2,460
Average number of shares on a diluted basis
711.6
n/a
n/a
713.1
714.7
EPS, Group, fully diluted, adjusted (p)
322.8
n/a
n/a
312.8
344.3

Disclaimer

Earnings forecasts are produced by the contributing registered investment analysts currently covering RB.

The estimates that are used to compile the consensus are the sole responsibility of the registered investment
analysts. RB uses Vuma to compile the consensus information, and does not endorse or concur with such analyst
information, conclusions or recommendations. RB has not verified any of the information received and none of RB,
its affiliates or any of its or their respective directors, officers and employees make any representation or warranty,
express or implied, as to, or accepts any responsibility for, the accuracy or completeness of the consensus
information. RB shall not be liable (whether in contract, tort or otherwise) for any errors, inaccuracies or omissions in
the content of the information (either at the date of issue of these forecasts, or any other date), or for any action
taken in reliance thereon. RB does not assume any responsibility to update, revise or supplement such information.

The information provided by RB is for information purposes only and is not intended for trading purposes. It should
be noted that forecasts are forward-looking and are therefore subject to risks and uncertainties (including unknown
risks and uncertainties) that may materially affect eventual results.

THE FORECASTS PROVIDED ARE BASED ON A MEAN AVERAGE OF ESTIMATES PROVIDED AND DO NOT
REPRESENT OR REFLECT, AND SHOULD NOT BE DEEMED TO BE, RB'S OPINIONS, ESTIMATES OR
FORECASTS.